Hypermethylationin promoter regions of CpG islands of multiple genes is associated with disease progression and molecular response in chronic myelogenous leukemia

被引:0
|
作者
Sumi, Mamta P. [1 ]
Guru, Sameer A. [1 ]
Najar, Imtiyaz A. [1 ]
Zuberi, Mariyam [1 ]
Gupta, N. [1 ]
Saxena, Alpena [1 ]
机构
[1] Maulana Azad Med Coll, New Delhi, India
关键词
D O I
10.1158/1538-7445.AM2019-831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
831
引用
收藏
页数:2
相关论文
共 41 条
  • [1] Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis
    Uehara, Eisuke
    Takeuchi, Seisho
    Yang, Yang
    Fukumoto, Tetsuya
    Matsuhashi, Yoshiko
    Tamura, Takahiro
    Matsushita, Masahide
    Nagai, Masami
    Koeffler, H. Phillip
    Tasaka, Taizo
    [J]. ONCOLOGY LETTERS, 2012, 3 (01) : 190 - 192
  • [2] Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia
    Yang, Y
    Takeuchi, S
    Hofmann, WK
    Ikezoe, T
    van Dongen, JJM
    Szczepanski, T
    Bartram, CR
    Yoshino, N
    Taguchi, H
    Koeffler, HP
    [J]. LEUKEMIA RESEARCH, 2006, 30 (01) : 98 - 102
  • [3] Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia
    Uehara, E
    Takeuchi, S
    Tasaka, T
    Matsuhashi, Y
    Yang, Y
    Fujita, M
    Tamura, T
    Nagai, M
    Koeffler, HP
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (03) : 693 - 696
  • [4] Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia
    Matsushita, C
    Yang, Y
    Takeuchi, S
    Matsushita, M
    Van Dongen, JJM
    Szczepanski, T
    Bartram, CR
    Seo, H
    Koeffler, HP
    Taguchi, H
    [J]. ONCOLOGY REPORTS, 2004, 12 (01) : 97 - 99
  • [5] Methylation of the ABL promoter in chronic myelogenous leukemia (CML) correlates with disease progression
    Willer, A
    Krämer, A
    Saussele, S
    Hochhaus, A
    Seifarth, W
    Hehlmann, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 283 - 283
  • [6] Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression
    Brazma, D.
    Grace, C.
    Howard, J.
    Melo, J. V.
    Holyoke, T.
    Apperley, J. F.
    Nacheva, E. R.
    [J]. GENES CHROMOSOMES & CANCER, 2007, 46 (11): : 1039 - 1050
  • [7] Disease progression in chronic myelogenous leukemia (CML) is linked to methylation of the ABL promoter.
    Willer, A
    Kramer, A
    Saussele, S
    Hochhaus, A
    Seifarth, W
    Hehlmann, R
    [J]. BLOOD, 1997, 90 (10) : 865 - 865
  • [8] DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia
    Garcia-Manero, G
    Daniel, J
    Smith, TL
    Kornblau, SM
    Lee, MS
    Kantarjian, HM
    Issa, JPJ
    [J]. CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2217 - 2224
  • [9] Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia
    Rani, Lata
    Gupta, Ritu
    Mathur, Nitin
    Singh, Kamya
    Gogia, Ajay
    Sundar, Durai
    Kumar, Lalit
    Sharma, Atul
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 173 - 174
  • [10] Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia
    Jelinek, Jaroslav
    Gharibyan, Vazganush
    Estecio, Marcos R. H.
    Kondo, Kimie
    He, Rong
    Chung, Woonbok
    Lu, Yue
    Zhang, Nianxiang
    Liang, Shoudan
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    Issa, Jean-Pierre J.
    [J]. PLOS ONE, 2011, 6 (07):